(Q41066935)

26 September 2017

Molecular characterization of the cyclin-dependent kinase inhibitor p27 promoter (English)

1 reference

26 September 2017

Y Zhang

1

1 reference

PubMed ID

9349726

26 September 2017

S C Lin

series ordinal

2

1 reference

26 September 2017

1 September 1997

1 reference

Biochimica et Biophysica Acta

26 September 2017

1 reference

26 September 2017

1353

1 reference

26 September 2017

3

1 reference

26 September 2017

307-317

1 reference

The Cyclin-dependent Kinase Family

26 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2897%2900063-8

7 January 2021

G1 phase progression: cycling on cue

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2897%2900063-8

7 January 2021

Cyclins and cyclin-dependent kinases: take your partners

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2897%2900063-8

7 January 2021

D-type cyclin-dependent kinase activity in mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2897%2900063-8

7 January 2021

Identification of G1 kinase activity for cdk6, a novel cyclin D partner

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2897%2900063-8

7 January 2021

Formation and activation of a cyclin E-cdk2 complex during the G1 phase of the human cell cycle

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2897%2900063-8

7 January 2021

Principles of CDK regulation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2897%2900063-8

7 January 2021

Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2897%2900063-8

7 January 2021

Rules to replicate by

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2897%2900063-8

7 January 2021

Reversal of terminal differentiation and control of DNA replication: cyclin A and Cdk2 specifically localize at subnuclear sites of DNA replication

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2897%2900063-8

7 January 2021

Mitosis in transition

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2897%2900063-8

7 January 2021

The MO15 gene encodes the catalytic subunit of a protein kinase that activates cdc2 and other cyclin-dependent kinases (CDKs) through phosphorylation of Thr161 and its homologues

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2897%2900063-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2897%2900063-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0167-4781%2897%2900063-8

1 reference

7 January 2021

Cell cycle. Dams and sluices.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2897%2900063-8

7 January 2021

Cdk inhibitors: on the threshold of checkpoints and development

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2897%2900063-8

7 January 2021

Joining the complex: cyclin-dependent kinase inhibitory proteins and the cell cycle

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2897%2900063-8

7 January 2021

Arresting developments in cell-cycle control

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2897%2900063-8

7 January 2021

Inhibitors of mammalian G1 cyclin-dependent kinases

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2897%2900063-8

7 January 2021

p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2897%2900063-8

7 January 2021

A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2897%2900063-8

7 January 2021

Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2897%2900063-8

7 January 2021

WAF1, a potential mediator of p53 tumor suppression

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2897%2900063-8

7 January 2021

A novel inhibitor of cyclin-Cdk activity detected in transforming growth factor beta-arrested epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2897%2900063-8

7 January 2021

p21 is a universal inhibitor of cyclin kinases

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2897%2900063-8

7 January 2021

p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2897%2900063-8

7 January 2021

Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2897%2900063-8

7 January 2021

Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2897%2900063-8

7 January 2021

Interleukin-2-mediated elimination of the p27Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2897%2900063-8

7 January 2021

Cyclic AMP-induced G1 phase arrest mediated by an inhibitor (p27Kip1) of cyclin-dependent kinase 4 activation.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2897%2900063-8

7 January 2021

Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2897%2900063-8

7 January 2021

p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2897%2900063-8

7 January 2021

Requirement of p27Kip1 for restriction point control of the fibroblast cell cycle

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2897%2900063-8

7 January 2021

Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1).

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2897%2900063-8

7 January 2021

A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2897%2900063-8

7 January 2021

Translational control of p27Kip1 accumulation during the cell cycle

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2897%2900063-8

7 January 2021

Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2897%2900063-8

7 January 2021

Spacing and orientation of bipartite DNA-binding motifs as potential functional determinants for POU domain factors

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2897%2900063-8

7 January 2021

Analysis of Sp1 in vivo reveals multiple transcriptional domains, including a novel glutamine-rich activation motif

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2897%2900063-8

7 January 2021

Isolation of cDNA encoding transcription factor Sp1 and functional analysis of the DNA binding domain

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2897%2900063-8

7 January 2021

Functional analysis of the transforming growth factor beta responsive elements in the WAF1/Cip1/p21 promoter

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2897%2900063-8

7 January 2021

10.1016/S0167-4781(97)00063-8

Identifiers

DOI

1 reference

26 September 2017

1 reference

PubMed ID

9349726